InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,880.10
(
-1.16%
)
US TECH 100
19,919.60
(
-2.10%
)
Dow Jones
43,485.88
(
-0.61%
)
Brent Oil
72.18
(
-0.05%
)
Bitcoin
89,115.84
(
2.03%
)
Post# of 253614
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 86186

Thursday, 11/12/2009 5:59:57 AM

Thursday, November 12, 2009 5:59:57 AM

Post# of 253614
Since Gamunex is, as you noted, Talecris's biggest product, and it is facing a future competition from Baxter's IGIV, I was thinking, maybe this puts extra pressure on Talecris to move on with its inhaled AAT program. Talecris like Kamada also got an orphan drug designation and if approved first, they may block Kamada's inhaled AAT.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up